Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maculopathies, Age-Related”

1,428 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,428 results

Testing effectiveness (Phase 2)Study completedNCT01136252
What this trial is testing

Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
Hospital Universitari Vall d'Hebron Research Institute 5
Early research (Phase 1)Study completedNCT00950638
What this trial is testing

ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration

Who this might be right for
Dry Age-Related Macular Degeneration
Ophthotech Corporation 47
Not applicableLooking for participantsNCT04847635
What this trial is testing

Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration

Who this might be right for
Macular Degeneration, SenileLaser Burn of RetinaMacular Degeneration Intermediate+1 more
Ospedale San Raffaele 50
Not applicableStudy completedNCT02279537
What this trial is testing

Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMD

Who this might be right for
Wet Macular Degeneration
Bayer 593
Post-approval studies (Phase 4)Study completedNCT02305238
What this trial is testing

Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Bayer 288
Large-scale testing (Phase 3)Study completedNCT00470678
What this trial is testing

EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-Related Macular Degeneration
Novartis 95
Testing effectiveness (Phase 2)Looking for participantsNCT06659549
What this trial is testing

Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

Who this might be right for
Geographic Atrophy of the Macula
Galimedix Therapeutics Inc 110
Not applicableStudy completedNCT01442064
What this trial is testing

An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Genentech, Inc. 608
Early research (Phase 1)Ended earlyNCT00102115
What this trial is testing

Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Light Sciences LLC 27
Early research (Phase 1)Active Not RecruitingNCT06825858
What this trial is testing

A Phase I, Open-label, Multicenter, Dose-Escalating Study to Evaluate the Safety and Tolerability of KH658 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Chengdu Origen Biotechnology Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT01445548
What this trial is testing

Sirolimus for Advanced Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationGeographic Atrophy
National Eye Institute (NEI) 6
Not applicableStudy completedNCT01692938
What this trial is testing

Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO

Who this might be right for
Age-Related Macular DegenerationGeographic AtrophyDiabetic Retinopathy+6 more
Optos, PLC 32
Not applicableStudy completedNCT01298674
What this trial is testing

Epidemiological Study of the Prevalence of Age-Related Macular Degeneration in Portugal

Who this might be right for
Age-Related Macular Degeneration
Association for Innovation and Biomedical Research on Light and Image 6,023
Not applicableUnknownNCT00640640
What this trial is testing

The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age Related Macular Degeneration
Sheba Medical Center 60
Testing effectiveness (Phase 2)UnknownNCT00996684
What this trial is testing

Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
University of California, Los Angeles 30
Not applicableStudy completedNCT00348543
What this trial is testing

Prophylactic Laser Treatment of Drusen Maculopathy

Who this might be right for
Age-related Macular Degeneration
University Hospital, Linkoeping 150
Post-approval studies (Phase 4)UnknownNCT03468296
What this trial is testing

Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept

Who this might be right for
Neovascular Age-related Macular Degeneration
Tennessee Retina 22
Post-approval studies (Phase 4)Study completedNCT04679935
What this trial is testing

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 52
Not applicableStudy completedNCT04984590
What this trial is testing

Early Feasibility Study Using IOPCL MAG to Improve Near Vision in ARMD Subjects

Who this might be right for
Low VisionAge Related Macular Degeneration
OnPoint Vision Inc 9
Not applicableUnknownNCT02158624
What this trial is testing

Ranibizumab Treatment for Age-Related Macular Degeneretion

Who this might be right for
Visual Disorder Due to Age-related Macula Degeneration
Kyushu University 100
Load More Results